Comprehensive preclinical research capabilities to accelerate clients' antipsychotic drug development.

Our preclinical psychiatric research technology platform integrates advanced behavioral, molecular, and neuroimaging tools

Ace Therapeutics offers validated cell-based models to support early-stage drug discovery, mechanism elucidation, and target validation for psychiatric disorders.

Ace Therapeutics accelerates psychiatric disease research and drug development by offering non-human primate (NHP) models and preclinical CRO services. Please refer to this brochure for more details.

Ace Therapeutics offers validated schizophrenia models with advanced behavioral platforms and multi-modal analysis, enabling customized solutions for mechanistic research, drug screening, and preclinical efficacy evaluation.

Comprehensive preclinical research capabilities to accelerate clients' antipsychotic drug development.